JPMorgan Leads 5 Stocks Near Buy Points Fueled By Earnings

Earnings season is in full swing, and a number of stocks are making strong moves as quarterly results roll in. Financial giant JPMorgan Chase (JPM) is testing a buy point near record highs after clearing estimates last week.

AI-related play Amphenol (APH) is also hovering near an entry, along with alloy maker Carpenter Technology (CRS). ResMed broke out following its Thursday night results. On Holding rallied Friday on the back of a strong beat from competitor Deckers Outdoor (DECK).

↑
X

NOW PLAYING
S&P 500 Giants Report Earnings. Will Megacap Results Sustain The Tech Rally?

On Holding

Hoka maker Deckers Outdoor (DECK) led a sprint for footwear stocks on Friday after a strong Q2 2025 beat.

Rival On Holding (ONON) leapt 6.45% after the report, rebounding decisively above its 50-day moving average and break a short downtrend.

SwingTrader added ONON shares with a 3/4 position on Friday at a 50.65 entry.

On hasn’t released a date for its Q3 results yet. But FactSet analysts expect flat earnings per share vs. a year earlier on nearly 32% revenue growth to $711 million.

ONON stock has rallied 88% so far this year. Shares are approaching their record high of 55.87 from November 2021.

Amphenol

Amphenol, a manufacturer of cables, sensors, circuits and connectors for data centers, delivered a record beat-and-raise Q3 report on Wednesday and noted a boost in sales from an increase in artificial intelligence applications.

Baird in a research note on Thursday said Amphenol’s AI and non-AI applications drove excellent IT data-communications growth. But the company’s AI-related strength is really driving accelerating business momentum.

Amphenol earnings and revenue growth accelerated over the last four quarters, to a 28% gain and a 26% increase, respectively.

APH stock is hovering below a 70.48 buy point for a 17-week consolidation. Shares tested the entry on Wednesday before easing.

Amphenol stock rose 2.9% to 69.42 for the week. is up 40% this year and trading around record highs.

ResMed

CPAP producer ResMed broke out on its Q3 earnings Friday, shrugging off concerns that popular weight-loss drugs would hamper demand for its sleep apnea machines.

Adjusted earnings increased 34% to $2.20 per share, clearing expectations for $2.05 per share. Sales rose 11% to $1.22 billion to beat estimates for $1.19 billion.

The results marked four consecutive quarters of accelerating earnings growth.

RMD stock spiked 7.1 Friday to bound above its 50-day line and just clear a 255.18 flat base buy point.

The current buy zone, which stretches 5% beyond the buy point, extends to 267.93.

ResMed stock is up 49% this year.

JPMorgan Chase

JPM stock is trading right below a 225.48 buy point for a cup base — also its record high — after JPMorgan Chase cleared Q3 estimates on Oct. 11.

The Dow Jones bank reported earnings of $4.37 per share on $42.7 billion in revenue, while FactSet expected $3.99 per share on $41.43 billion.

The S&P 500 giant tested the buy point a few times since earnings but hasn’t been able to score a decisive breakout.

JPM stock dipped below its 10-day line on Friday but is holding above its other key moving averages.

JPMorgan has advanced more than 30% in 2024.

Carpenter Technology

Carpenter Technology on Wednesday topped Q2 2025 earnings estimates and CEO Tony Thene said it was the most profitable first quarter in company history. Adjusted earnings for the Philadelphia-based alloy maker nearly doubled to $1.73 per share, outpacing FactSet expectations for $1.58 per share. However, revenue only rose 10% to $718 million, while analysts expected $743 million.

Carpenter said it expects 2025 operating income to be at the high end of its previous guidance for $460 million to $500 million, but that was short of analyst estimates for $502 million.

The company guided Q2 operating income between $116 and $123 million, with the midpoint above analyst forecasts for $117 million.

CRS stock briefly undercut its 50-day line and a 148.98 buy point Thursday after its sales and guidance miss, but pared losses significantly. Carpenter edged higher on Friday, just below its 21-day line. The stock is technically back in a buy zone for its Sept. 18 breakout.

But investors perhaps should focus on an emerging consolidation, which could turn into a flat base after another week. Use Wednesday’s high of 161.70 as an early entry.

Carpenter Technology shares rocketed more than 119% this year and hit an all-time high of 166.51 on Sept. 26.

You can follow Harrison Miller for more stock news and updates on X/Twitter @IBD_Harrison

YOU MAY ALSO LIKE:

Best Growth Stocks To Buy And Watch: See Updates To IBD Stock Lists

Looking For The Next Big Stock Market Winners? Start With These 3 Steps

Join IBD Live And Learn Top Chart Reading And Trading Techniques From Pros

Learn How To Time The Market With IBD’s ETF Market Strategy

The Nasdaq Is At Highs. These 5 Earnings Could Change Everything.